This content is machine translated Therapy for stress hyperglycemia Which insulin is best for glycemic control? Hyperglycemia leads to poorer clinical outcomes, with increased morbidity and mortality in both critically ill and non-critically ill people. Improving blood glucose levels reduces length of hospital stay, systemic infections...…
View Post 3 min This content is machine translated T2D: Pioglitazone as an add-on to metformin and dapagliflozin Effective strategy for improving blood glucose control Type 2 diabetes (T2D) is a progressive disease characterized by a deterioration in the function of pancreatic β-cells and increased insulin resistance. Although there are many diabetes medications on the…
View Post 5 min This content is machine translated Insulin icodec Once-weekly injection as an opportunity for greater adherence Over the last century, significant advances have been made in the development of insulin formulations, including very rapid and prolonged-release analogs of basal insulin. Insulin icodec, a novel basal insulin…
View Post 5 min This content is machine translated Type 2 diabetes: reduction of microvascular and macrovascular risks The extensive toolbox has a lot to offer The fact that most type 2 diabetics today aim for an HbA1c value of <7% is partly due to the results of the UKPDS. This landmark study showed that the…
View Post 3 min This content is machine translated Case report: Gastrointestinal complications due to DPP4 inhibitors Linagliptin induced pancreatitis DPP4 inhibitors are often used to control blood glucose levels. An increasing number of papers have reported the risk between DPP4 inhibitors and acute pancreatitis (AP); however, the evidence is…
View Post 5 min This content is machine translated Diabetic ketoacidosis One third could be treated without insulin Diabetic ketoacidosis (DKA) is a serious hyperglycemic complication in people with diabetes. Physicians in sub-Saharan Africa conducted a prospective cohort study of adults newly diagnosed with diabetes who developed DKA…
View Post 4 min This content is machine translated Pharmacotherapy for people over 80 A case of age discrimination? SGLT2 inhibitors and GLP1 receptor agonists have emerged as the drugs of first choice in the guidelines for type 2 diabetes. Sulfonylureas and insulin, on the other hand, were deprioritized…
View Post 9 min This content is machine translated Diabetes Technology CGM can optimize therapy control for T1D and T2D Modern technologies are becoming increasingly important for both type 1 diabetes (T1D) and type 2 diabetes (T2D). More and more patients are turning to continuous glucose monitoring (CGM). By coupling…
View Post 3 min This content is machine translated Type 2 diabetes: insulin therapy - quo vadis? Basic insulin with once-weekly injection convinces An ultra-long-acting insulin analogue that only needs to be injected once a week is currently in development. The results of the clinical studies to date are promising. Insulin Icodec has…
View Post 6 min This content is machine translated Diabetes treatment Insulin therapy in type 2 diabetics: an update. The most modern representatives of basal insulins are ultra-long acting and associated with low hypoglycemia rates. Mixed insulin or combination preparations of GLP-1-RA and a long-acting insulin are good alternatives…
View Post 5 min This content is machine translated Type 2 diabetes: SGED recommendations update Reduction of cardiovascular complications as top priority Prevention of microvascular and macrovascular complications is an important overarching goal in the management of type 2 diabetes, and the current SGED guidelines have further informed decision making in cardiovascular…
